The FDA approval of the CFTR modulator, Kayldeco, in 2012 changed the paradigm of CF healthcare by providing a…
Stephen Shannon
Stephen Shannon is working on a PhD In biomedical sciences at the Kansas University Medical Center in Kansas City, Kansas. He performed extensive research in a neuroendocrinology lab as an undergraduate, studying the effects of brain injury on the development of post-traumatic stress disorder. Upon completion of his BS at Wheaton College, he worked as a high school science teacher before entering his current PhD program. Stephen also has cystic fibrosis.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Stephen Shannon
Just Breathe: Adults living with Cystic Fibrosis is a newly released book that captures the human experience…
Dorothy Andersen, M.D., was the first to write a full report describing cystic fibrosis in 1938, and since her initial…
In a previous article I referenced the first portion of the Nature Review, “cystic…
Cystic fibrosis was ushered into the spotlight during President Barack Obama’s 2015 State of the Union Address as he highlighted…
Although I am a student in a biomedical science program I have only begun in the past two years…
In November, the Cystic Fibrosis Foundation sold their royalty rights for CF related drugs developed by…
My little sister, Jennifer, was a beautiful woman who, like myself, fought Cystic Fibrosis throughout her life and on Saturday,…
In this week’s editorial column, Cystic Fibrosis News Today’s Stephen Shannon sounds off on the recent news of the…
In his first weekly column for Cystic Fibrosis News Today, PhD student and CF patient Stephen Shannon talks candidly about…